Stock REMUS REMUS PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Remus Pharmaceuticals Limited

Equities

REMUS

INE0O5T01011

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-05-31 am EDT 		5-day change 1st Jan Change
7,431 INR +3.19% Intraday chart for Remus Pharmaceuticals Limited -2.43% -2.91%
May. 31 790,000 Equity Shares of Remus Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 31-MAY-2024. CI
May. 16 Remus Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
790,000 Equity Shares of Remus Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 31-MAY-2024.
CI
Remus Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Remus Pharmaceuticals Limited Declare Second Interim Dividend for the Financial Year 2023-24
CI
Remus Pharmaceuticals Limited Announces Setting Up of Branch Office in Dubai
CI
Remus Pharmaceuticals Limited entered into a Memorandum of Understanding to acquire a 51% stake in Espee Biopharma & Finechem LLC for $2.7 million.
CI
Remus Pharmaceuticals Limited has completed an IPO in the amount of INR 476.852 million.
CI
Remus Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
CI
Remus Pharmaceuticals Limited has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REMUS Stock
  4. News Remus Pharmaceuticals Limited